MUC5AC mucin release from human airways in vitro: Effects of indomethacin and Bay X1005
Background: Increased secretion of mucus is a hallmark of many respiratory diseases and contributes significantly to the airflow limitation experienced by many patients. While the current pharmacological approach to reducing mucus and sputum production in patients is limited, clinical studies have s...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | 圖書 |
| 出版: |
Hindawi Limited,
2001-01-01T00:00:00Z.
|
| 主題: | |
| 在線閱讀: | Connect to this object online. |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 總結: | Background: Increased secretion of mucus is a hallmark of many respiratory diseases and contributes significantly to the airflow limitation experienced by many patients. While the current pharmacological approach to reducing mucus and sputum production in patients is limited, clinical studies have suggested that drugs which inhibit the cyclooxygenase and/or 5-lipoxygenase enzymatic pathways may reduce secretory activity in patients with airway disease. |
|---|---|
| Item Description: | 0962-9351 1466-1861 10.1080/09629350124329 |